Nonselective β-blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients

UK guidelines on the management of variceal haemorrhage in cirrhotic patients

(2015) Dhiraj Tripathi et al.   GUT

Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis

(2014) Mattias Mandorfer et al.   GASTROENTEROLOGY

When Should the β-Blocker Window in Cirrhosis Close?

(2014) Phillip S. Ge et al.   GASTROENTEROLOGY

To block, or not to block in advanced cirrhosis and ascites: that is the question

(2014) Aleksander Krag et al.   GUT

Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation

(2014) Joanna A Leithead et al.   GUT

Beta-blockers in cirrhosis patients with refractory ascites

(2013) Anne Robins et al.   HEPATOLOGY

Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices

(2012) M. Thiele et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease: Figure 1

(2012) Aleksander Krag et al.   GUT

Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity

(2011) Florence Wong et al.   GUT

Is hydrophobia necessary for the hepatologist prescribing nonselective beta-blockers in cirrhosis?

(2011) Marco Senzolo et al.   HEPATOLOGY

Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for Physicians

(2011) William H. Shrank et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study

(2011) Thomas Sersté et al.   JOURNAL OF HEPATOLOGY

Beta-blockers in cirrhosis: Friend and foe?

(2010) Florence Wong et al.   HEPATOLOGY

Is this really the end of beta-blockers in patients with cirrhosis and refractory ascites?

(2010) Thierry Thevenot et al.   HEPATOLOGY

Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites

(2010) Gin-Ho Lo   HEPATOLOGY

Beta-blockers in patients with cirrhosis and refractory ascites

(2010) Albillos Agustín et al.   HEPATOLOGY

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

(2010) Thomas Sersté et al.   HEPATOLOGY

Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites

(2009) A Krag et al.   GUT

The management of portal hypertension: Rational basis, available treatments and future options

(2008) Jaime Bosch et al.   JOURNAL OF HEPATOLOGY